M1A.159
Lead-induced chronic gout, unspecified hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced chronic gout is a form of gout caused by long-term exposure to lead, which can lead to joint inflammation and pain, particularly in the hip. Gout is a condition characterized by the buildup of uric acid crystals in the joints, leading to intense discomfort. When associated with lead exposure, this condition can become chronic and more complicated to treat.
Causes & Symptoms
Clinical Causes: Prolonged exposure to lead, commonly through contaminated water, soil, or occupational settings such as mining or manufacturing. Ingesting lead particles through contaminated food or water sources. Chronic inhalation of lead fumes or dust. Working in environments with poor lead safety measures.
Key Symptoms: Persistent pain and swelling in the hip joint. Stiffness and reduced range of motion in the affected hip. Tenderness and warmth over the joint. Possible formation of tophi—hard urate deposits under the skin near the joint. General discomfort and fatigue due to chronic inflammation.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of lead-induced chronic gout involves a combination of clinical evaluation and laboratory tests: - Medical history focusing on potential lead exposure. - Blood tests measuring blood lead levels. - Urinalysis for elevated uric acid levels. - Joint aspiration to analyze synovial fluid for uric acid crystals. - Imaging studies such as X-rays or MRI to identify joint damage and tophi.
Treatment Protocols: Managing lead-induced chronic gout typically focuses on alleviating symptoms, reducing uric acid levels, and addressing lead exposure: - Chelation therapy to reduce lead levels in the body. - Medications such as NSAIDs or corticosteroids to control joint inflammation and pain. - Uric acid-lowering drugs like allopurinol or febuxostat. - Lifestyle modifications including dietary changes to limit purine intake. - Removal from lead exposure sources and implementing safety measures. - Regular monitoring of blood lead and uric acid levels. - Physical therapy to improve joint function and mobility.
Clinical Advice & FAQs
Billing Guidance
Is M1A.159 a billable ICD-10 code?
Yes, M1A.159 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.159?
Clinical documentation must specify the nature of Lead-induced chronic gout, unspecified hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference